Baricitinib effectiveness in patients with alopecia universalis and rheumatoid arthritis

Ital J Dermatol Venerol. 2022 Dec;157(6):535-536. doi: 10.23736/S2784-8671.22.07348-0.

Authors

Annunziata Dattola¹, Chiara Pensa², Maria S Chimenti³, Alberto Bergamini³, Arianna D'Antonio³, Sara Lambiase², Elena Campione², Luca Bianchi²

Affiliations

¹ Department of Dermatology, Tor Vergata University, Rome, Italy - nancydattola@gmail.com.
² Department of Dermatology, Tor Vergata University, Rome, Italy.
³ Department of Rheumatology, Allergology and Clinical Immunology, Tor Vergata University, Rome, Italy.

PMID: 36651214
DOI: 10.23736/S2784-8671.22.07348-0

No abstract available

MeSH terms

Alopecia / drug therapy
Arthritis, Rheumatoid* / complications
Arthritis, Rheumatoid* / drug therapy
Azetidines* / therapeutic use
Humans

Substances

baricitinib
Azetidines

Supplementary concepts

Alopecia universalis